By ELIZABETH MERAB More by this AuthorKenya is expected to receive a new drug that has been found to shorten the recovery period of Covid-19 patients. Remdesivir, a drug developed to treat Ebola, was approved for emergency use on Covid-19 patients two months ago. GENERIC VERSIONSKenya is among 126 low-income and lower middle income countries identified by Gilead Sciences to receive generic versions of the drug. Remdesivir has also been approved as Covid-19 therapy in Japan, Taiwan, India, Singapore and the United Arab Emirates. TRIALLED FOR EBOLAThe drug, which was trialled for Ebola but failed to work as expected, is under patent to Gilead.

Source: Daily Nation July 09, 2020 06:56 UTC